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Knowledge of the architecture of DNA ligase IV
(LigIV) and interactions with XRCC4 and XLF-
Cernunnos is necessary for understanding its role
in the ligation of double-strand breaks during nonho-
mologous end joining. Herewe report the structure of
a subdomain of the nucleotidyltrasferase domain of
human LigIV and provide insights into the residues
associated with LIG4 syndrome. We use this struc-
tural information together with the known structures
of the BRCT/XRCC4 complex and those of LigIV
orthologs to interpret small-angle X-ray scattering
of LigIV in complex with XRCC4 and size exclusion
chromatography of LigIV, XRCC4, and XLF-Cernun-
nos. Our results suggest that the flexibility of the
catalytic region is limited in a manner that affects
the formation of the LigIV/XRCC4/XLF-Cernunnos
complex.
INTRODUCTION
DNA ligase IV (LigIV) plays a major role in ligation of double-
strand break (DSB) repair through nonhomologous end joining
(NHEJ). This is carried out in three main steps. First, two DNA
ends are brought together by DNA-dependent protein kinase
(DNA-PK, a complex of the Ku70/80 heterodimer and the DNA-
PK catalytic subunit [DNA-PKcs]) (Smith and Jackson, 1999).
Second, the ends may be processed by nucleases and polymer-
ases such as Artemis, polynucleotide kinase/phosphatase, and
DNA polymerase g and m (Lieber, 2010). Finally, the ends are
joined by ligase complex comprising LigIV, XRCC4, and XLF-
Cernunnos (XLF) (Grawunder et al., 1997; Critchlow et al.,
1997; Buck et al., 2006b; Ahnesorg et al., 2006).
DNA ligases I (LigI), III (LigIII), and LigIV share a common
architecture of the catalytic region including the DNA-binding
domain (DBD), the nucleotidyltransferase domain (NTase), and
the OB-fold domain (OBD) (Ellenberger and Tomkinson, 2008).
DBD was first identified in the structure of LigI and is important
for DNA joining of the ligase (Pascal et al., 2004). The same
domain was observed in LigIII (Cotner-Gohara et al., 2010) and
archaeal DNA ligases (Pascal et al., 2006; Nishida et al., 2006;
Kim et al., 2009). Six conserved motifs are present in NTase1212 Structure 20, 1212–1222, July 3, 2012 ª2012 Elsevier Ltd All rigand OBD (Shuman and Schwer, 1995), which are important for
the three steps of DNA ligation (Shuman and Lima, 2004). NTase
has the ATP-grasp fold (Murzin, 1996) and is a member of the
glutathione synthetase ATP-binding domain-like superfamily,
comprising two subdomains that have the RAGNYA fold (Balaji
and Aravind, 2007) and the phosphatidylinositol phosphate
kinase (PIPK) C-terminal-like fold (Grishin, 1999). In the DNA-
bound form of DNA ligases (Pascal et al., 2004; Nair et al.,
2007; Cotner-Gohara et al., 2010), the subdomain with the RAG-
NYA fold is located at the 50 end of a DNA nick (here called
NTase-5), while the second subdomain lies at the 30 end of
a DNA nick (here called NTase-3).
In addition to these conserved catalytic domains, human DNA
ligases have other domains at their N- and C-termini (Ellenberger
and Tomkinson, 2008). LigIV has a tandem repeat of BRCT
domains at its C-terminus, which is responsible for the interac-
tion with its partner protein XRCC4 (Critchlow et al., 1997). Since
LigIV is unstable without XRCC4 (Bryans et al., 1999), it is
believed to be present predominantly in the complex form
(LX4). Structural studies of human LX4 and its yeast ortholog
Lig4p/Lif1p have shown that the BRCT domains of LigIV encircle
the coiled-coil of the XRCC4 homodimer mainly via a conserved
linker between the domains (Sibanda et al., 2001; Dore´ et al.,
2006; Wu et al., 2009).
Negative-stain electron microscopy of the full-length complex
(Recuero-Checa et al., 2009) indicate that the XRCC4 C-terminal
domain (X4CTD) adopts a globular architecture giving rise to
a compact structure of the whole complex. However, the failure
of three-dimensional reconstruction of the complex implies
heterogeneity in the conformation. SAXS (small angle X-ray
scattering) studies of the BRCT domains and the full-length
XRCC4 suggest that X4CTD is disordered but folds back toward
the N-terminus of XRCC4 (Hammel et al., 2010). The structure of
the catalytic region of LigIV and its relative arrangement with
respect to the remaining part of LX4 remain unresolved.
LX4 forms a complex with XLF mainly via the head domains of
XRCC4 and XLF (Ahnesorg et al., 2006; Deshpande and Wilson,
2007). Different groups have recently shown that the XRCC4/XLF
complex assembles as a left-handed filament (Ropars et al.,
2011; Hammel et al., 2011; Wu et al., 2011; Andres et al.,
2012). Although XLF forms multimers in the presence of
XRCC4 bound with the BRCT domains of LigIV (Andres et al.,
2007; Hammel et al., 2010), the impact of the catalytic region
of LigIV on XRCC4/XLF complex formation is unclear.
Here we report studies of LX4 using SAXS and X-ray crystal-
lography to gain insights into the structure of the catalytic regionhts reserved
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the catalytic region destabilizes the LX4/XLF complex. A model
of LigIV in complex with XRCC4 suggests that its limited flexi-
bility leads to competition with the formation of the filament by
XRCC4 and XLF.
RESULTS
Interaction Studies of Human DNA Ligase IV/XRCC4
and XLF
To define the effect of the catalytic region of LigIV on the XRCC4/
XLF complex, we investigated the interactions between the
three proteins using gel filtration chromatography. To eliminate
the possibility of a contribution from this domain to the formation
of the XRCC4/XLF complex and unnecessary higher order olig-
omer formation of XRCC4 though disulphide bonds, we used
XRCC4DCTD;CtoA, where X4CTD (residues 214–334) is omitted
and all cysteines are mutated to alanines. Interestingly, when
the catalytic region of LigIV was present, LX4DCTD;CtoA formed
a less stable complex with human XLF lacking residues 234-
299 (XLFDCTD) (Figures 1A and 1B); free XLFDCTD was always
observed in the constructs of the LX4 complex with the catalytic
region. Similar results were observed with a full-length LX4
construct (data not shown). Only when XRCC4DCTD;CtoA formed
a complex with the BRCT domains alone (LigIVDcat) could the
two proteins interact stably with XLFDCTD (Figures 1A and 1C).
The removal of DBD from LigIV (LigIVDDBD) did not stabilize the
complex between XRCC4DCTD;CtoA and XLFDCTD (Figures S1A
and S1B available online). These results suggest that the cata-
lytic core of LigIV prevents XLFDCTD from binding the head
domain of XRCC4DCTD;CtoA.
SAXS Studies of Human DNA Ligase IV/XRCC4
Because the gel filtration studies of the LigIV/XRCC4/XLF
complex implied that the catalytic region of LigIV may have
a well-defined conformation in relation to the remaining part of
LX4, SAXS studies of the complex were carried out to investigate
its overall shape. In addition to the full-length construct LX4, two
other truncated constructs LX4DCTD;CtoA and LDcatX4DCTD;CtoA,
the complex of LigIVDcat and XRCC4DCTD;CtoA were investigated.
The linearity of the Guinier plots [graph of the natural logarithm
of the scattered intensity I(s) versus s2 at very low angles] sug-
gested that the solution samples were well behaved and
monodisperse (Figure S2A). Rg of LX4, LX4
DCTD;CtoA and
LDcatX4DCTD;CtoA are 70.1, 55.3, and 46.3 A˚, and their Dmax are
222, 179, and 136 A˚ (Ochi et al., 2010). The deletion of X4CTD
reduced Rg and Dmax by 15 A˚ and 43 A˚ respectively, while dele-
tion of the catalytic region further decreased these values by 9 A˚
and 43 A˚, respectively. The scattering profiles of the three
constructs have few prominent features, such as shoulders or
inflection points, and these are primarily in the very low angle
scattering region, thus indicating an inherent conformational
plasticity (Figure 2A and 2B).
Ab initio 3D-shape reconstruction of LX4 did not provide
strong evidence for a conserved molecular shape because ten
individually restored models yielded conformations with a high
degree of variation (emphasized by a NSD value of 1.06 for the
average model). In contrast, reconstructions for LX4DCTD;CtoA
yielded NSD values of 0.81 for the average 3D shape (OchiStructure 20, 1et al., 2010), which is elongated with an additional region of scat-
tering density when the structure of LDcatX4DCTD (Wu et al.,
2009), was fitted into the averaged envelope (Figure 2C; Fig-
ure S2C). The fitting was performed with eight different orienta-
tions, correlation coefficients (CCs) of which were calculated
using UCSF Chimera (Pettersen et al., 2004) (models 1–8 in Fig-
ure S2D). Models 1 and 3 had the two highest CCs and extra
densities were concentrated either near the BRCT domains of
LigIV or the head domains of XRCC4 (left and right Figure 2C,
respectively). These results imply that LX4 has an extended
shape and the catalytic region of LigIV may have a well-defined
structure near the BRCT or head domains.
Crystallographic Structure of NTase-3 of Human
DNA Ligase IV
Although we gained information about the overall shape of LX4
from SAXS studies, the structural details of the N-terminal
catalytic domains—DBD, NTase, and OBD—of LigIV remained
unresolved. Therefore, we set out to define their structures by
X-ray protein crystallography. We crystallized a subdomain of
NTase (NTase-3) of human LigIV and solved the structure at
the resolution of 2.9 A˚ using SAD and SIRAS methods (see
Experimental Procedures for the details). The combination of
the phases thus obtained provided electron density that allowed
us to build a model of NTase-3 at 3.5 A˚ resolution. The model
was further refined at 2.9 A˚ resolution, which gave an 84%
complete model with an R/Rfree of 27/30% (Table 1). The posi-
tions of methionine residues were confirmed by calculating
the anomalous difference maps using the model and SeMet
data (Figure S3B and Table 2). The structure revealed an overall
architecture of the NTase-3 of LigIV that is similar to that of LigI
(Pascal et al., 2004) and LigIII (Cotner-Gohara et al., 2010) (Fig-
ure S3C). LigIV has a six amino acid insert, which is relatively
acidic, between b2 and 310 defined by residues of low conserva-
tion across species (Figure 3A and Figure S4). The relative
arrangement of motifs I, III, and IIIa resembles that of the other
human DNA ligases, suggesting that LigIV carries out DNA liga-
tion in a conventional manner. An extended polypeptide at the
N-terminus (Figure 3B), which is supposed to form a b sheet in
NTase-5 (Figure S5B), is stabilized by forming a fireman’s grip
with a corresponding peptide belonging to another asymmetric
unit in crystal (data not shown).
Rigid-Body Modeling of Human DNA Ligase IV/XRCC4
To gain further insights into the structure of the catalytic region of
LigIV, homology models of DBD, NTase, and OBD were created
using Modeller (Sali and Blundell, 1993). Then, the structure of
NTase-3 was used as a template for the NTase model (see
Experimental Procedures). The SAXS data of LX4DCTD;CtoA
were further analyzed by rigid-bodymodeling using BUNCH (Pe-
toukhov and Svergun, 2005) as described in Experimental
Procedures. The average c2 of ten individual rigid-body models
against the scattering data was 5.64 ± 0.50. Although they had
differing conformations, the catalytic domains were found near
the BRCT domain and were placed near the first BRCT domain
in the models having the three lowest c2 (Figure 4A). Taken
together with the ab initio modeling of LX4DCTD;CtoA, our SAXS
studies suggest that in solution the catalytic region stays near
the BRCT domains rather than the head domain of XRCC4.212–1222, July 3, 2012 ª2012 Elsevier Ltd All rights reserved 1213
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Figure 1. Gel Filtration Chromatography Studies of Complex Formation of LigIV, XRCC4DCTD;CtoA, and XLFDCTD
(A) Profiles of the UV absorbance at 280 nm during gel filtration chromatography. Colors of profiles and their corresponding constructs are shown at the bottom of
the figure. Gray arrows indicate peak positions of protein standards, void, ferritin (440 kDa), aldolase (158 kDa), conalbumin (75 kDa), ovalbumin (43 kDa),
carbonic anhydrase (29 kDa), and RNase A (13.7 kDa).
(B) SDS-PAGE of LX4DCTD;CtoA and XLFDCTD fractions eluted from a Superdex 200 10/30 column. The molecular weight markers are in column ‘‘M’’ column and
their molecular weights (kDa) are shown on the left of the gel. The fraction ranges used for the SDS-PAGE are indicated using a blue arrow in (A). Each fraction
contained 250 ml of the eluted sample.
(C) SDS-PAGE of LDcatX4DCTD;CtoA and XLFDCTD eluted from the gel filtration column. The fractions used for SDS-PAGE are indicated alphabetically (green a-n)
both in (A) and in the gel.
(D) Schematic representation of the constructs used in the gel filtration experiment. The domain names and boundaries are shown in LX4DCTD;CtoA and XLFDCTD. In
XRCC4DCTD;CtoA and XLFDCTD, HD, CC, and FB represent head, coiled-coil, and fold-back domains, respectively.
See also Figure S1.
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Figure 2. SAXS Studies of LX4
(A) Experimental scattering curves of LX4
constructs. The scattering intensities (log I versus
s-value) with error bars (gray) of LX4 (blue),
LX4DCTD;CtoA (green) and LDcatX4DCTD;CtoA (blue)
are displaced by factor of 100 for clarity. The
scattering curves of the latter two constructs were
modified after Ochi et al., 2010.
(B) Distance distributions of LX4 constructs. The
same color scheme as in (A) is used in this figure.
The error bars are represented with gray.
(C) Shape reconstruction of LX4DCTD;CtoA. The
molecular envelope of LX4DCTD;CtoA is shown in
two perpendicular orientations, which derived
from an averaging process of several, individually
restored 3D shapes. The structure of a LX4
construct (PDB code: 3II6; Wu et al., 2009). The
structure was fitted into the envelope manually
and refined using Chimera (Pettersen et al., 2004).
The two structural superimpositions providing the
highest correlation correlations coefficients are
illustrated to highlight additional molecular density
not present in the crystal structure.
See also Figure S2.
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structural units of the complex, we expressed and purified
individual domains of the catalytic region: DBD, NTase, and
OBD. Gel retardation assays of these domains, the BRCT
domains and the XRCC4 (residues 1–334; LDcatX4) domain did
not demonstrate any interactions between them (Figure 4B,
left). Since the OBD-620 (residues 457–620) used for the assays
did not contain the linker region (residues 621–653), a further
construct, OBD-653 (residues 457–653) was expressed with an
N-terminal GST tag and purified. However, as this resulted in
an insoluble protein after tag cleavage, OBD-653 was purified
without removing the tag (GST-OBD-653). GST pull-down
assays were carried out using GST-OBD-620 and GST-OBD-
653. The results showed that GST-OBD-653 did not have
a strong interaction with LDcatX4 (Figure 4B, right). Thus, we
were not able to substantiate an interaction between the cata-
lytic region of LigIV and its BRCT domains and/or XRCC4.
Insights into aDNA-BindingRegion of NTase-3 of Human
DNA Ligase IV
NTase-3 of DNA ligases has a DNA-binding region and loop
immediately after b1 (D1) and the other between b3 and b4 (Fig-
ure S4). The latter is mostly disordered in the crystals studied
here. The Ser/Arg motif in D1 (S292/R293), conserved in human
DNA ligases (Figure S4), is located in a similar position to those
in LigI and LigIII [S588(I)/R589(I) and S440 (III)/R441(III) in Fig-Structure 20, 1212–1222, July 3, 2012 ªure 5]. In LigIV, position 298 is occupied
by a tyrosine instead of the aspartate
[D594(I)], which forms a hydrogen bond
with the phosphate at position 12 of the
DNA backbone in the LigI structure (Fig-
ure 5). At an equivalent position, LigIII
has a conserved valine [V446(III) in Fig-
ure 5], which does not establish direct
contacts with DNA but is involved inhydrophobic interactions to fix the DNA-binding region D1.
With the exception of a few organisms in which histidines and
phenylalanines are located in the equivalent position (data not
shown), Y298 is conserved among LigIVs suggesting that this
residue may play a role in DNA binding.
LIG4 Syndrome Mutation in NTase-3 of Human
DNA Ligase IV
R278, Q280, and H282, mutations of which cause LIG4
syndrome, are located on b1 in the same way as the equivalent
residues of LigI and LigIII (Figure S5A). Because they probably
play similar roles in DNA ligation, their mutation will likely lead
to disruption of important interactions, as described below in
the Discussion. A further mutation Y288C in mouse LigIV results
in LIG4 syndrome (Nijnik et al., 2007). Some organisms have
phenylalanine instead of tyrosine at this position (Figure S4).
This tyrosine residue forms a part of the hydrophobic core of
the NTase-3 domain and a hydrogen bondwith H316 (Figure 6A),
suggesting that the mouse Y288C substitution impairs the
stability of NTase-3. As shown below, an analysis of the Y288C
mutation indicates that it stabilizes the structure of NTase.
However, the domain may not have an identical conformation,
and this may affect the shape of the ATP-binding pocket and
the activity of the enzyme.
To gain further insights into the role(s) of these residues, the
structure of the entire NTase of LigIV was built using Modeller2012 Elsevier Ltd All rights reserved 1215
Table 1. Values for the Structural Model of NTase-3
Resolution (A˚) 30.6–2.9
Rcryst
a (%) (the highest shell) 27.3 (30.4)
Rfree
b (%) (the highest shell) 30.5 (39.1)
Structural model
Number of atoms (non H) 952
RMSD bond (A˚) 0.014
RMSD angle () 1.971
Ramachandran outliersc (%) 0.8
Rotamer outliersc (%) 7.4
aRcryst = SkFobsj-jFcalck/SjFobsj, Fobs and Fcalc are observed and calcu-
lated structure factor amplitudes.
bRfree as for Rcryst using a random subset of the data (about 10%)
excluded from the refinement.
cCalculated with phenix.refine module of PHENIX suite (Adams et al.,
2010).
Structure
Structural Insights into Human DNA Ligase IVwith the NTase-3 structure of LigIV and the experimentally
defined domains from LigI (Protein Data Bank [PDB] code:
1X9N), LigIII (PDB code: 3L2P), and archeal DNA ligases (PDB
codes: 2HIV, 2CFM, and 3GDE) as templates (Figure S5B). The
possible effects of several substitutions were investigated
using the SDM server (Worth et al., 2011). Solvent accessibilities
of R278, Q280, H282 and Y288 were 15.9, 1.6, 0.1, and 0.1%
respectively. Calculated pseudo DDG values of R278H,
Q280R, H282L, and Y288C substitutions found in LIG4 syn-
drome were 0.53,1.50, 2.88, and 1.68, respectively. The muta-
tions except for Q280R are predicted to stabilize the NTase
domain. With the exception of R278, these residues are solvent
inaccessible and highly hydrogen-bonded, suggesting that they
play structural roles in NTase.
DISCUSSION
The overall shape of LX4 has been studied using SAXS in com-
bination with X-ray crystallography and homology modeling.Table 2. X-Ray Diffraction Data
Crystal Native-1 Native-2
Source Beamline ESRF ID14-1 In-house PROTEU
Wavelength (A˚) 0.9765 1.5418
Resolution (A˚) 100-2.90 33.48-3.50
Space group P4122 P4122
Cell (A˚)
a = b 39.09 38.93
c 197.39 196.98
Number of unique reflections 3860 2278
Completeness (%) (the
highest resolution shell)
98.8 (100)a 99.4 (98.3)
Redundancy 11.9 72.2
Rsym
b (%) (the highest shell) 6.3 (54.4) 33.98 (107)
I/s (the highest shell) 15.3 (5.2) 18.3 (0.9)
aThe numbers in parentheses represent the statistics for the highest resolu
bRsym =
P
hjI h - < I > j/
P
hI h, where Ih is the intensity of reflection h, and <
1216 Structure 20, 1212–1222, July 3, 2012 ª2012 Elsevier Ltd All rigThe position of themaximumof the distance distribution function
is shifted toward the origin compared withDmax/2, suggesting an
elongated shape (Svergun and Koch, 2003). The Kratky plots of
LX4DCTD;CtoA and LX4 show characteristic bell-shaped profiles
reminiscent of folded and/or compact macromolecules (Fig-
ure S2B). A SAXS study of Sulfolobus solfataricus DNA ligase,
which contains the catalytic region only, indicates an open
conformation with a Dmax of about 120 A˚ in solution (Pascal
et al., 2006). A similar result has been recently reported for the
catalytic region of LigIII; however, an advanced SAXS data
analysis strategy has revealed multiple conformations of LigIII
in solution, although 74% of them are open structures (Cotner-
Gohara et al., 2010). These reports imply that LigIV is likely to
adopt a predominantly open conformation, a notion that is sup-
ported by our rigid-body analysis LX4DCTD;CtoA from SAXS data.
BecauseDmax of L
Dcat X4DCTD;CtoA is 136 A˚, the observedDmax of
LX4DCTD;CtoA should be over 200 A˚ instead of 179 A˚ if the cata-
lytic region of LigIV had an extended structure. LX4 has an addi-
tional 43 A˚ extension, which is a contribution from X4CTD. If the
domain were folded back toward the head domain of XRCC4
giving a compact structure, it should not increase the size of
LX4DCTD;CtoA to that extent. Thus, X4CTD may be flexibly linked
with the other domains. This is supported by a SAXS study of the
BRCT domains of LigIV and full-length XRCC4 (Hammel et al.,
2010).
The SAXS study in solution of LX4DCTD;CtoA defines an
ensemble of extended and compact conformations, and rigid-
body modeling indicates that in some of these the catalytic
region is likely to be located near the BRCT domains. Indeed,
the catalytic region of LigIV may be flexibly connected to the
domains but limited in its movement, as suggested by electron
microscopy studies of negative stained LX4 (Recuero-Checa
et al., 2009). It has also been suggested that the flexibility of
the catalytic region of LigIV could be required to facilitate the
repair of various types of DSBs (Perry et al., 2010).
The limited movement of the catalytic region might be partly
responsible for the inefficiency of the re-adenylation of LX4. It
is known that DNA ligases with DBD, NTase, and OBD domainsSeMet Hg Os
M X8 ESRF ID14-1 ESRF ID14-1 Diamond I02
0.9795 1.007 1.140
65.02-3.50 65.19-3.40 97.54-3.60
P4122 P4122 P4122
39.00 39.14 39.22
195.07 195.56 195.37
2223 2447 2127
99.9 (100) 99.9 (99.9) 100 (100)
12.0 12.1 11.9
9.4 (44.6) 9.4 (67.0) 13.0 (63.8)
14.8 (5.2) 14.6 (4.2) 10.3 (4.1)
tion shell.
I > is the mean intensity of all symmetry-related reflections.
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Figure 3. Structure of NTase-3
(A) Overall architecture of NTase-3. Conserved
motifs I, III and IIIa are shown in purple, pink and
yellow. Dotted lines represent missing loops
(gray and pink) connecting DNA-binding regions
D1 and D2 (pink).
(B) A schematic presentation of secondary struc-
ture elements of NTase-3.
See also Figure S3.
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Structural Insights into Human DNA Ligase IVundergo large conformational changes in order to adenylate
NTase (Pascal et al., 2004). Thus, if themovement of the catalytic
region is restricted, the efficiency of re-adenylation will be
reduced. However, the initial adenylation of LigIV is highly effi-
cient: about 99% of LX4 was pre-adenylated in cells (Chen
et al., 2009). Since LigIV in the free form is also likely to be
difficult to re-adenylate (Wang et al., 2007), the highly efficient
initial adenylation of LigIV seems to be a unique feature of this
protein. The interaction with XRCC4 likely causes a conforma-
tional change in LigIV, which stimulates LigIV adenylation.
Our gel filtration data show that the presence of the catalytic
region of LigIV destabilizes the formation of the XRCC4/XLF
complex. Although we observed the formation of the LigIV/
XRCC4/XLF complex, it was less stable than the complex using
LDcatX4DCTD;CtoA (Figures 1B and 1C). Since we also observed
the LDcatX4DCTD;CtoA/XLF complex using gel filtration (Figures
1A and 1C), EMSA (data not shown), and electrospray ionization
mass spectrometry (data not shown), our results are still compat-
ible with results reported by others showing that LDcatX4DCTD in
the presence of XLF forms filaments (Andres et al., 2007; Ham-
mel et al., 2010). The XRCC4/XLF filament is likely to exist given
that there are more XRCC4 molecules than LigIV in vivo (ManiStructure 20, 1212–1222, July 3, 2012 ªet al., 2010). However, the structure of
the filament may be altered in the pres-
ence of the full-length LigIV. The removal
of DBD from LigIV did not greatly affect
the destabilization of the XRCC4/XLF
complex, suggesting that NTase and/or
OBD may clash with XLF. These results
imply that the catalytic core is located,
for at least some of the time, where it
can cause stereochemical clashes with
XLF, probably near the head domain of
XRCC4. Alternatively, because XLF
seems to have physical contacts with
the BRCT1 (Wu et al., 2009), it may
compete with the catalytic region of
LigIV. Ku70/80 might also mediate the
interaction because it was detected
by pull-down assays using whole cell
extracts of MRC5 cells, and both XLF,
which is DNA-dependent (Yano et al.,
2008), and BRCT1 (Costantini et al.,
2007) interact with Ku70/80. It is reported
that XLF and its yeast ortholog Nej1
assist re-adenylation and de-adenylation
of LigIV (Riballo et al., 2009; Chen and
Tomkinson, 2011). XLF might free thecatalytic region to make it possible to change its conformation
for re-adenylation. If the catalytic region of LigIV is located
near BRCT1, one of the head domains of XRCC4 in the LX4 is
more likely to interact with XLF than the other; thus, LX4 may
prefer to occupy a position at the end of the XRCC4/XLF
filament. This would ensure that the ligase interacts with Ku70/
80 and DNA ends for DSB end joining.
The structure of NTase-3 and a homology model of NTase
of LigIV demonstrate the structural importance of R278,
Q280, H282 and Y288. The homology model of NTase of LigIV
indicates that R278 will likely establish a hydrogen bond with
the carbonyl oxygen of M249 and a salt bridge with D329 (Fig-
ure 6B). Interestingly, substitution of M249 to valine also results
in LIG4 syndrome (Toita et al., 2007). Since these residues
belong to the other subdomain of NTase (NTase-5; see Intro-
duction), the interactions may stabilize the structure of the
catalytic pocket by fixing the relative position of NTase-3
and -5. In addition, in the structure of LigI, the corresponding
arginine makes a hydrogen bond with the 30-OH of the AMP
ribose (Pascal et al., 2004). The corresponding arginine (R39)
makes the same hydrogen bond with ATP in T7 DNA ligase
(Subramanya et al., 1996). Indeed, the mutation to histidine2012 Elsevier Ltd All rights reserved 1217
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Figure 4. Rigid-BodyModeling and Protein-
Protein Binding Assays of Human DNA
Ligase IV/XRCC4 Complex
(A) Rigid-body modeling of LX4DCTD;CtoA using
BUNCH. Ten individual rigid-body models were
superposedon thestructureof theLDcatX4DCTD;CtoA
region. Themodels with the three highest c2 values
are shown in a cartoon representation and the
others are shown as their Ca traces.
(B) Left: EMSAs of individual catalytic domains
and LDcatX4. The proteins used are indicated with
‘‘+.’’ Right: GST pull-down assays of OBD and
LDcatX4. The upper and lower figures show the
results of the assays using GST-OBD-620 and
GST-OBD-653, respectively. The first lane protein
markers (M) are followed by unbound proteins (U)
and bound proteins (B) to GST affinity resin.
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Structural Insights into Human DNA Ligase IVimpairs the interaction with ATP resulting in inefficiency of
adenylation as observed experimentally (Riballo et al., 1999).
Therefore, the substitution R278H is likely to lead to instability
of the ATP-binding pocket and the interaction with ATP. A
similar proposal has been made on the basis of the structure
of T4 DNA ligase (Riballo et al., 2001).
The catalytic pocket is further stabilized by Q280 and H282
via interactions with the N-terminal peptide of NTase (residue
242–249) (Figure 6C). LIG4 syndrome mutant Q280R may fail
to form hydrogen bonds with the peptide, and, as a result, might
destabilize the catalytic pocket of NTase. V(D)J recombination
was undetectable in LIG4 gene null cells that instead carry the
LIG4Q280R gene; however, in vitro studies of the Q280R mutant
showed that it joined DNA nicks as efficiently as the wild-type
protein (Buck et al., 2006a). This implies that the Q280R mutant
has normal ligation activities. Since there are hydrophobic resi-
dues around H282 (Figure 6C), the mutation H282L is likely to
result in the stabilization of NTase as suggested by the SDM
analysis. However, the mutation no longer makes the hydrogen
bond with Q280 and may change the conformation of the
catalytic pocket. Because experimental data of the H282L
mutant are unavailable, it is difficult to assess the impact of the
mutation. Since R278, Q280, and H282 all interact with the
N-terminal peptide of NTase, it is likely that the peptide is impor-
tant for stabilizing the conformation of the catalytic pocket of
NTase. This is also supported by a recent report demonstrating
that conserved buried polar residues that are hydrogen-bonded1218 Structure 20, 1212–1222, July 3, 2012 ª2012 Elsevier Ltd All rights reservedare important for the stabilization of
protein structures (Worth and Blundell,
2010). Interestingly, the peptide and the
following b strand are unique to polynu-
cleotide ligase and mRNA capping
enzymes in the glutathione synthetase
ATP-binding domain-like superfamily.
Thus, they may be important for polynu-
cleotide binding. Apart from R278 they
are not directly involved in the catalytic
activity of LigIV, so the instability of the
ATP-binding pocket is likely to impair
the LigIV/AMP complex formation (Rib-
allo et al., 1999; O’Driscoll et al., 2001).Another LIG4 syndrome mutant R814X, which lacks the second
BRCT domain, does not form the LigIV/AMP complex (Girard
et al., 2004), suggesting that the adenylation of LigIV is very inef-
ficient but not null in the mutations causing LIG4 syndrome. This
means that we should be able to rescue the adenylation of the
LigIV mutants if we could develop drugs that are analogs of
ATP, which bind the catalytic pockets of the proteins and form
a lysine/AMP intermediate.
In summary, we have described experiments that shed further
light on both the structure of individual domains and the
ensemble of conformers adopted by DNA ligase IV. X-ray anal-
ysis of NTase-3 of human LigIV has defined the structure of
this subdomain and suggested structural roles for the residues,
mutations of which cause LIG4 syndrome. With respect to the
complete structure of this multimodular enzyme, we have shown
that there is only limited movement of the catalytic region of DNA
ligase IV and this prevents formation of a continuous filament
formation of the XRCC4/XLF complex. Crystallographic studies
of the LigIV/XRCC4/XLF complex, including the catalytic region,
remain of central importance to gain insights into the regulation
of complex formation and the nature of interactions at DSB sites.EXPERIMENTAL PROCEDURES
Purification of Human LigIV/XRCC4 Constructs
The LX4 co-expression plasmid was a gift from Prof. Ming-Daw Tsai. LX4 was
expressed in Rossetta2(DE3) (Invitrogen) and purified as described previously
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Figure 5. Comparison of the DNA-Binding Loop D1 of NTase-3
The structure of NTase-3 of LigIV (cyan) is shown together with that of LigI
(I, pink; PDB code: 1X9N) and LigIII (III, blue; PDB code: 3L2P), and DNA
(PDB code: 1X9N). Backbone phosphates of DNA are labeled as 12 and 13.
The pink-dotted lines represent hydrogen bonds between LigI and the DNA.
The original residue numbers of the phosphates shown in the PDB file are
used here.
See also Figure S4.
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Structural Insights into Human DNA Ligase IV(Wang et al., 2007). The XRCC4 gene was amplified from an XRCC4DCTD;CtoA
expression plasmid, the protein of which has a residue range between 1 and
213 only and all cysteines are mutated to alanines (Sibanda et al., 2001) and
cloned between NdeI and AvrII sites of the multiple cloning region (MCR) 2
of pRSFDuet1 vector (Novagen). Then, the LIG4 and LIG4DDBD, which do not
have DBD, were amplified from the co-expression plasmid and cloned
between NcoI and EcoRI sites of MCR 1 of the pRSFDuet1. LX4DCTD;CtoA
and LDcatX4DCTD;CtoA were expressed in Rossetta2(DE3)pLysS (Invitrogen).
Genes of individual domains of LigIV, DBD (residues 1–244) and OBD (458–
620) were amplified from the LX4 co-expression plasmid and cloned into
pGAT3 vectors (J. Pera¨nen and M. Hyvo¨nen, personal communication), which
carry GST tags at their N-termini. NTase (residue 245–457) was cloned into
pHAT5, which has a hexa-histidine tag at the C-terminus (Pera¨nen et al.,
1996). The domains were expressed in BL21(DE3) (Invitrogen). Purification
protocols of these constructs are described in Supplemental Experimental
Procedures.
Size Exclusion Chromatography
1800 pmol of XLFDCTD was mixed with the same quantity of LX4DCTD;CtoA,
LDcatX4DCTD;CtoA or LDDBD X4DCTD;CtoA and incubated in 50 ml of reaction buffer
(20 mM Tris-HCl pH 8.0 at 4C, 150 mMNaCl, 5% [v/v] glycerol, 5 mMDTT) on
ice for 60 min before loading onto a Superdex 200 10/300 (Pharmacia) column
equilibrated with reaction buffer; 1800 pmol of those proteins were also indi-
vidually loaded onto the column without incubation. High- and low-molecular
weight markers (GE Healthcare) were loaded onto the column by following
their guidelines.
Crystallization and Data Collection
Ten mg/ml of NTase was mixed with 1/100 volume of 10 mg/ml papain from
JBS Floppy-Choppy (Jena Bioscience) just before the crystallization trials of
NTase. In the hanging drop method used here, 1.5 ml of crystallization agents
(6%–8.5% [w/v] PEG6000, 100 mM MES pH 5.5–5.7, 4% [v/v] 2-propanol)
were added to each drop containing an equal volume of the mixed protein
solution on a siliconized cover glass placed against reservoir containing
600 ml of the agents. SeMetNTase was crystallized in a similar way in a different
crystallization solution (17% [w/v] PEG6000, 100 mM MES pH 6.2, 10 mMStructure 20, 1betain hydrochloride). The sequence of the crystallized protein was confirmed
by SDS-PAGE (Figure S3A) followed by mass spectrometry and N-terminal
sequencing conducted by Dr. Len Packman and Mr. Mike Weldon at the
PNAC Facility in the Department of Biochemistry, Cambridge University. To
prepare a heavy atom derivative of the NTase, crystals were soaked in their
reservoir solutions containing 1 mM thiomersal (Hg) for 2 hours or 0.1 mM
osmium chloride (Os) overnight. Crystals of NTase and SeMetNTase were
transferred to cryo-protectant solutions (30% of ethylene glycol mixed with
70% of crystallization agents) and frozen in liquid nitrogen. X-ray diffraction
data collection experiments were carried out at either ESRF (Grenoble, France)
or Diamond (Oxford, UK) synchrotron radiation sources. One native dataset
(native-2) was collected using an in-house rotating anode X-ray generator
(Proteum X8, Bruker AXS) at the X-ray crystallographic facility at the Depart-
ment of Biochemistry, University of Cambridge to obtain a high redundancy
dataset.
Data Processing
Crystallographic data statistics of the collected X-ray diffraction datasets of
NTase-3 are described in Table 2. X-ray diffraction data of the derivative
crystals were processed usingMOSFLM (Battye et al., 2011). Native-1 dataset
was processed using HKL suite (Otwinowski and Minor, 1997), whereas
native-2 dataset was processed using PROTEUM2 (Bruker AXS, Madison,
WI). The scaling of the integrated data was carried out using Scala (Evans,
2006) for the derivative data and Scalepack (Otwinowski and Minor, 1997)
for the native datasets. The space group of the crystals was determined
as P4122 based on the reflection conditions of the crystal, a self-rotation
function calculated from Molrep (Vagin and Teplyakov, 1997) and the results
of Pointless (Evans, 2006).
Structure Solution and Model Building
Experimental phases were calculated from (1) the SeMet data using SAD
methods, (2) Os and Hg data sets (Os/Hg phases) using SIRAS methods,
and (3) native-2 and Hg data sets (native-2/Hg phases) using SIRAS methods.
Multi-crystal averaging of these data was carried out using DMMULTI
(Cowtan, 1994) to calculate phases for native-1 at the maximum resolution
of 3.5 A˚. The model of NTase-3 was built using Coot (Emsley et al., 2010).
The phenix.refine and phenix.autobuilt modules in PHENIX suite with
secondary structure and Ramachandran restraints (Adams et al., 2010) and
Refmac 5.5 were used for refinement of the model. The refinement was then
carried out using native-1 up to 2.9 A˚ resolution using PHENIX and the jelly-
body refinement in Refmac 5.6 (Murshudov et al., 2011). The refinement
and re-building of the model using Coot were repeated until there was no
further improvement; the R/Rfree of the final model were 27/30%, respectively
(Table 1). Each molecule representation was generated with PyMOL (Delano
Scientific, San Carlos, CA) or UCSF Chimera (Pettersen et al., 2004). A more
detailed description of the model building can be found in the Supplemental
Experimental Procedures.
Modeling of the Catalytic Region of Human DNA Ligase IV
Sequences of orthologs of LigIV were obtained using protein BLAST (Altschul
et al., 1990) and aligned using Muscle (Edgar, 2004). For the sequence align-
ment of LigIVs, 11 nonredundant sequences were selected. In parallel, protein
structures of LigIV homologs (human LigI [PDB code: 1X9N]; Pascal et al.,
2004), human LigIII (PDB code: 3L2P; Cotner-Gohara et al., 2010), and three
archeal DNA ligases (PDB codes 2HIV [Pascal et al., 2006], 2CFM [Nishida
et al., 2006], and 3GDE [Kim et al., 2009]) were downloaded from RSBC
PDB (Berman et al., 2000), and were structurally aligned using BATON (D.F.
Burke, personal communication). The structural alignment template files
were converted to FUGUE input files, and then aligned with the Muscle align-
ment files using Fugueali (Shi et al., 2001). The combined alignment files were
represented in JOY format (Mizuguchi et al., 1998) and manually refined using
SeaView (Gouy et al., 2010) when necessary.
Structural models of the individual catalytic domains of LigIV were created
using Modeller (Sali and Blundell, 1993) based on the sequence alignment of
the DNA ligases. As for the model of NTase, the crystallographic structure of
NTase-3 of LigIV was included in the structural templates described above.
The best model that had the lowest object function was selected from212–1222, July 3, 2012 ª2012 Elsevier Ltd All rights reserved 1219
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Figure 6. Interactions of Residues that
Cause LIG4 Syndrome that Are Close to
the Catalytic Residues of Human LigIV
(A) Hydrophobic core of NTase-3 of LigIV around
Y288 (magenta). Since the electron density for the
side chains of K283 and I315 was not observed,
the amino acids were represented as alanines.
(B) Interactions in the model between R278
(magenta) and surrounding residues.
(C) Interactions between Q280/H282 and
surrounding residues. Salt bridges and hydrogen
bonds are represented using black dotted lines.
See also Figure S5.
Structure
Structural Insights into Human DNA Ligase IV30 created models. The predicted impact of amino acid residue substitutions
of NTase was carried out with the program SDM (Worth et al., 2011).
Small-Angle X-Ray Scattering
SAXS data collection was performed at station 2.1, Synchrotron Radiation
Source, Daresbury Laboratory UK, with a two-dimensional multiple-wire
proportional counter. The radius of gyration, the maximum particle dimension
and the distance distribution function were calculated with GNOM (Svergun,
1992). DAMMIN (Svergun, 1999) was used for the ab initio shape reconstruc-
tion of the proteins. Subsequent rigid-body modeling of LX4DCTD;CtoA was per-
formed using BUNCH (Petoukhov and Svergun, 2005), after which we used the
crystallographic structure of the complex of the BRCT domains of LigIV and
XRCC4 (PDB code: 3II6; Wu et al., 2009), and homology models of DBD,
NTase, and OBD (see above). The UCSF Chimera package (Pettersen et al.,
2004) was used to visualize the model envelopes. See Supplemental Experi-
mental Procedures for the details.
ElectrophoreticMobility Shift Assay for Protein-Protein Interactions
Protein-protein interaction studies using electrophoretic mobility shift assays
were carried out based on a published protocol (Andres et al., 2007). Proteins
were incubated in 20 ml of the binding buffer (20 mM Tris-HCl pH 7.5 at 25C,
50 mM KCl, 0.1 mM DTT, 5% [v/v] glycerol) at 25C for 60 min. The incubated
samples were directly loaded into Tris-HCl pH 8.0 at 4C 5% polyacrylamide
gel and separated by electrophoresis at 80 V in TBE for 110 min. The gel
was stained and visualized with Coomassie blue.
GST-Pull-down Assays
GST-pull-down assays were carried out according to a reported protocol (Ei-
narson, 2001). Ten micrograms of GST fusion proteins were mixed with 1:1
molar ratio of LDcatX4, which is the complex of the BRCT domains of LigIV
(residues 654–911) with a N-terminal hexa-histidine tag and XRCC4 (residues
1–334). They were incubated with 25 mg GST resin at 4C in the reaction buffer
(20 mM Tris-HCl pH 8.0 at 4C, 200 mM NaCl, 1 mM EDTA, 0.5% [v/v] NP-40)
for 120 min. After washing the resin twice with the reaction buffer, the bound
proteins were eluted with the reaction buffer plus 20 mM reduced glutathione.1220 Structure 20, 1212–1222, July 3, 2012 ª2012 Elsevier Ltd All rigACCESSION NUMBERS
The PDB accession number for the coordinate of NTase-3 of human DNA
ligase IV, together with the structure factors, reported in this paper is 3VNN.
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